Implant Makes HIV, Diabetes, and Appetite Drugs

ChatGPT Ads Hit $100M, Self-Serve Starts in April

ChatGPT’s ads feature grew fast, reaching about $100 million in annualized revenue in around six weeks, even though fewer than 20% of eligible users see ads daily.

Ads show below responses, mostly to free users, and don’t affect answers or use private chats.

Right now about 600 advertisers are in a limited pilot, but in April OpenAI will open self-serve ads so businesses can run their own campaigns.

This could turn ChatGPT into a major ad platform, especially since users often ask for recommendations.

Hayden AI Sues Ex-CEO Over $1.2M Stock Sale and Data Theft

Hayden AI sued its former CEO, Christopher Carson, saying he forged signatures and secretly sold about $1.2 million in stock, then used it to buy a $2.7 million Florida home.

They also claim he took 41GB of company data and started a rival, EchoTwin AI, which raised about $8 million.

The case is still ongoing, and the claims aren’t proven.

This article says this shows startup risks and notes that insurance may cover legal costs but not fraud if proven.

Reddit Cracks Down on Bots

Reddit is adding human verification checks and clear labels for approved bots.

Accounts that seem automated may need to prove they’re human, and unlabeled bots could be restricted or removed to stop spam and fake activity.

For brands, this means bot-driven marketing won’t work as well.

Reddit is pushing for real human engagement, so brands need to focus on genuine interaction.

HOBIT Implant Makes HIV, Diabetes, and Appetite Drugs in the Body

Scientists created a tiny implant called HOBIT that works like a living pharmacy inside the body.

It uses engineered cells to continuously make multiple drugs at once, including an anti-HIV antibody, a GLP-1 diabetes treatment, and an appetite hormone.

In animal tests, the implant delivered steady doses for about 30 days and even produced its own oxygen to keep the cells alive.

This could one day replace daily pills or injections with a single implant for people with chronic conditions.